Shares rose Thursday after results showed Pfizer announced positive results Wednesday for an early-stage vaccination trial. Pfizer said that patients created 1.8 to 2.8 times the antibodies seen in those who recovered from COVID-19. A market analyst said that the “V-shaped recovery gnomes, once again, are getting to heaven.” But …
Read More »